The origins of Novo Nordisk and Novartis products: piloting a framework to identify the public contributions.

Fabian D, Sehic O, Wild C

Open source

DOI
10.1080/20523211.2025.2534919
Published
2025
Container
Journal of pharmaceutical policy and practice
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/20523211.2025.2534919,
  title = {The origins of Novo Nordisk and Novartis products: piloting a framework to identify the public contributions.},
  author = {Fabian D and Sehic O and Wild C},
  year = {2025},
  journal = {Journal of pharmaceutical policy and practice},
  doi = {10.1080/20523211.2025.2534919},
  url = {https://doi.org/10.1080/20523211.2025.2534919}
}

RIS

TY  - JOUR
TI  - The origins of Novo Nordisk and Novartis products: piloting a framework to identify the public contributions.
AU  - Fabian D
AU  - Sehic O
AU  - Wild C
PY  - 2025
JO  - Journal of pharmaceutical policy and practice
DO  - 10.1080/20523211.2025.2534919
UR  - https://doi.org/10.1080/20523211.2025.2534919
ER  - 

APA

D, F., O, S., & C, W. (2025). The origins of Novo Nordisk and Novartis products: piloting a framework to identify the public contributions.. Journal of pharmaceutical policy and practice. https://doi.org/10.1080/20523211.2025.2534919

Source records